April 25th, 2013

Voting Results from Johnson & Johnson’s Annual Meeting of Shareholders

By Doug Chia, Assistant General Counsel & Corporate Secretary, Johnson & Johnson

April 25th 2013 – Today, Johnson & Johnson held its 125th Annual Meeting of Shareholders in New Brunswick, NJ. Today’s shareholders meeting was Alex Gorsky’s first as Chairman of the Board of Directors.

Here is a recap of the official business from today’s meeting, including preliminary voting results:

1) Election of Directors: All 12 Director nominees were elected to serve one-year terms on the Board of Directors with a range of support of 87 to 99 percent of the votes cast. Alex Gorsky (Chairman/CEO) received the support of 97 percent. A full list of our Board members, including their biographies, can be found in the Corporate Governance section of the investor.jnj.com website.

2) Advisory Vote to Approve Named Executive Officer Compensation: In this advisory vote, our shareholders approved the company’s executive compensation philosophy, policies and procedures and the compensation of the executive officers named in the 2013 Proxy Statement with the support of 94 percent of the votes cast.

3) Ratification of Appointment of Independent Registered Public Accounting Firm: Our shareholders approved the appointment of PricewaterhouseCoopers LLP to serve as our independent auditors for 2013 with the support of 99 percent of the votes cast.

Read More

April 23rd, 2013

TEDMED 2013: Connecting with a Purpose

By Diego Miralles, Head of Janssen Healthcare Innovation and Johnson & Johnson Innovation, California


Janssen’s Diego Miralles and U.S. Surgeon General Regina Benjamin at TEDMED 2013

Last week in Washington D.C., I had the privilege of attending my third annual TEDMED conference on behalf of Johnson & Johnson. TEDMED can best be described as a multi-disciplinary community of innovators who share a common determination to create a better future in health and medicine. The meeting brings together approximately 2,000 delegates in person, plus tens of thousands of additional participants who join globally via remote satellite locations, including events at more than a dozen different Johnson & Johnson facilities across the world.

This year the theme of TEDMED was “Unexpected Connections”, and that is exactly what happened. We spent three days connecting with people to think together, challenge our ideas, build new relationships, and create new beginnings. I was proud that Johnson & Johnson had a very significant presence at this meeting demonstrating our commitment to the TEDMED movement. Many of our most senior leaders actively engaged in collaborative and future-focused discussions with entrepreneurs and start-up companies and our scientists were on hand to showcase our latest technologies and contribute to the dialogue.

Read More

April 22nd, 2013

Making Earth Day Part of Our Every Day

By Fadra Nally, Corporate Communications, Johnson & Johnson

When I was in college, I remember ordering a t-shirt with some of my hard-earned minimum wage pay that proudly celebrated the 20 year anniversary of Earth Day. That was in 1990.

If you do a little math and consult some history, you’ll find that Earth Day originated in 1970. A time of flower power and hippie culture, as well as some of the worst environmental pollution of our time.

Using the momentum from the war protests at the time, a U.S. Senator founded what would become Earth Day, a day of demonstration and education all in the name of a healthy, sustainable environment.

Remarkably, that original Earth Day led to the creation of the United States Environmental Protection Agency and the passage of the Clean Air, Clean Water, and Endangered Species Acts.

Since that anniversary in 1990, when Earth Day saw a resurgence of interest and went global, the campaigns and initiatives to protect our environment for future generations have increased exponentially.

Our Sustainability Campaign


At Johnson & Johnson, we’re extremely proud to talk about our contribution with Earthwards®, a program launched in 2009 for developing and marketing greener products through lifecycle thinking.

Read More

March 26th, 2013

Recognizing Diabetes Alert Day: One Mother’s Personal and Professional Journey

By Kelsey Ginck, Global Fellow, Corporate Communication, Johnson & Johnson

In honor of American Diabetes Alert Day, a one-day “wake up call” for learning your risk of diabetes, I asked my mom about her journey with diabetes — from her diagnosis and how it influenced her decision to become a diabetes educator at LifeScan Animas, to how her experiences have shaped where she is today, both personally and professionally.

Check out the full post over at JNJParents: http://jnj.me/14sSG4b

Read More

March 19th, 2013

Johnson & Johnson provides support to the Penn State Dance Marathon (THON)

By Kelsey Ginck, Corporate Communication Global Fellow at Johnson & Johnson, and Penn State Class of 2012.


One by one, numbers are lifted up until a final dollar sign is revealed and the THON 2013 total is greeted with screams and tears from thousands of student volunteers. The Penn State Dance Marathon (THON) shattered its previous record by raising $12,374,034.46 for kids with cancer. Johnson & Johnson was one of the leading sponsors of THON 2013, as we have been for many years, sharing in Penn State’s dream of conquering pediatric cancer. This year, I was there too, and I’m proud to be part of both organizations who are so committed to this cause.




Photo Credit: WWW.THON.ORG

THON is one of the most difficult things to explain to someone who’s never seen it with their own eyes. In its most basic form, the Penn State Dance Marathon is a yearlong fundraising effort, that culminates in February with a 46-hour no sitting, no sleeping dance marathon. All proceeds benefit the Four Diamonds Fund, an organization affiliated with the Penn State Hershey Children’s Hospital, which provides families facing pediatric cancer with comfort and financial support. Students spend time with Four Diamonds Families, as they are affectionately called, throughout the year and invite them to the big celebration in February.

Read More

March 14th, 2013

Supporting our Troops and Veterans: From Facebook to the Front Line

By Russell Clayton, National Chair of the Veterans Leadership Council and Senior Manager Supplier Governance,  Johnson  & Johnson Supply Chain


A few weeks ago Johnson & Johnson received a Facebook message from Donna McAndrews, a soldier currently serving overseas in Afghanistan. She wrote about the difficulties of women in uniform to feel feminine, explaining that supplies can be scarce. I didn’t hesitate when Donna requested a care package because, as a veteran, I remember how much those donations meant to my unit when we were overseas. It’s something you never forget. Thanks to the help of our Johnson & Johnson Veterans Leadership Council ( VLC) volunteers, we were able to send out five large (and heavy!) boxes full of Johnson & Johnson beauty and health care products to let these ladies know they have friends at Johnson & Johnson who care about them and appreciate their service.


The Veterans Leadership Council is one of ten Diversity and Inclusion employee resource groups at Johnson & Johnson. Our mission is to support Johnson & Johnson military and veteran associates and their families through a network of employee volunteers, who contribute their time outside of their regular job responsibilities. VLC programs focus on our three main pillars — people, community, and marketplace — by helping military members transition to civilian life, getting involved with our veteran communities, and bringing business value to Johnson & Johnson.

Read More

February 19th, 2013

A New Milestone in the Journey Toward Sustainable Palm Oil

By Simon Perry, Sourcing Manager for Sustainable Palm Oil, Johnson & Johnson Consumer Group

In the past, we’ve told you about Johnson & Johnson’s support of sustainable palm oil, like this blog post about our connection to a program at the Philadelphia Zoo. Although we are very small users overall of palm oil (less than 0.2% of the estimated 50 million tons produced a year) we take our responsibility to protect the environment and our natural resources very seriously. Now, we’re pleased to share with you the latest milestone in our journey to source palm oil sustainably, this time from another part of the world—Thailand.

As the Sourcing Manager for Sustainable Palm Oil within the Johnson & Johnson Consumer Family of Companies, I take pride in helping to drive our organization toward our commitment to sourcing sustainable palm oil. So it was with great enthusiasm that I recently witnessed an important milestone in this journey, involving a group of 412 independent palm oil farmers in Thailand.

These farmers have been certified by the Roundtable on Sustainable Palm Oil (RSPO), which means that they now meet the RSPO standards for sustainable palm oil planting and production. They’re able to realize better prices from the mills, produce more and also improve the quality of the fruit by employing better agricultural management practices.

Read More

February 13th, 2013

Distinct Innovation Model Sets Johnson & Johnson Apart

By: Michael McCaffrey, Senior Director, Johnson & Johnson Corporate Communication

Innovation is the lifeblood to success for any company competing in the healthcare industry.  When it comes to innovation, many healthcare companies have robust, longstanding processes that are highly standardized and easily repeatable over time.  However, many of these innovation processes have one shortcoming – they are often front loaded — ie, the bulk of attention is given to idea generation and refinement, with little or no upfront consideration to late stage elements like regulatory strategy, commercialization and access effects.  In a rush to market, this lack of foresight can lead to hasty decisions and a ‘push it through’ mentality resulting in poor launch execution and weaker than expected market performance.

At Johnson & Johnson we are focused on creating value through innovation.  We believe meaningful innovation derives from the insight and spirit of our employees, and their ability to anticipate and understand the needs of patients and what they value.  What’s truly unique about our innovation model is our insistence on early identification and development of downstream strategies to optimize everything from access to outcomes.  Our model is ‘end-to-end,’ meaning ingenuity is applied throughout the process of bringing innovation to market. 

Read More

February 12th, 2013

Janssen Scientists Challenge Industry to Create Integrated Approaches to Healthcare Innovation

We’re pleased to share the news that a group of scientists and business leaders from our Janssen team, along with a professor from the Harvard Business School, co-authored a new commentary in the February issue of the journal Nature Reviews Drug Discovery that addresses integrated approaches to healthcare solutions. Husseini Manji, Global Head of Neuroscience at Janssen Research & Development and Michael Yang, President of Janssen Pharmaceuticals, Inc. are two of the Janssen authors.

The authors challenge the healthcare industry to expand its thinking beyond product-focused, “magic bullet” drug development and discuss the need for an integrated approach to patient care, including use of devices, tools and services to help a patient’s progress. They discuss, for example, how people with serious mental illnesses, such as schizophrenia, are more likely to have better outcomes when they are involved in integrated care plans that involve more than a therapeutic and they look to a future when novel devices will help track and analyze patients’ progress.

This commentary, “Beyond magic bullets: true innovation in health care,” was published in the February 2013 issue of Nature Reviews Drug Discovery and is available here.

Read More

January 23rd, 2013

Neglected Tropical Diseases – Not Neglected by Johnson & Johnson

By: Steven A. Silber, MD, Compound Developer Team Leader, Flubendazole

One of the things that make me proud to be a Johnson & Johnson employee is the commitment and dedication of every person here to do the best we can for patients…especially for the world’s most disadvantaged. I am grateful to be leading the team working to more effectively treat lymphatic filariasis (elephantiasis) and onchocerciasis (river blindness), two of the most debilitating tropical diseases in the developing world.

To quote a new report from Uniting to Combat NTDs, an initiative with which J&J is affiliated, neglected tropical diseases (NTDs) are “a group of infectious diseases that disproportionally affect the world’s poorest and most vulnerable populations. It is estimated that more than one billion people are affected by NTDs, including roughly 800 million children. Although these diseases are the most common infections amongst the world’s poorest, they have traditionally received little or inconsistent attention on international health agendas. Targeted commitments and investments from a range of partners over the years have reduced the burden of many NTDs, but significant gaps still remain.”

In January of last year, Johnson & Johnson committed to collaborating with public and private partners to eliminate or control 10 NTDs by 2020, in what are the largest coordinated actions to date in support of the World Health Organization’s NTD goals.

Read More